A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: Baricitinib; Drug: Topical corticosteroid; Drug: Placebo Sponsors: Eli Lilly and Company; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials